Xenon Pharmaceuticals Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Xenon Pharmaceuticals Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2013 to Q3 2024.
  • Xenon Pharmaceuticals Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 75.8M shares, a 16.6% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 75.8M +10.8M +16.6% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 75.7M +11.9M +18.8% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 75.5M +12.4M +19.6% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 75.4M +12.8M +20.4% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 65M +2.46M +3.93% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 63.7M +1.48M +2.37% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 63.1M +10M +18.9% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 62.6M +11M +21.2% Dec 31, 2022 10-K 2024-02-29
Q3 2022 62.5M +21.1M +51% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 62.2M +21.1M +51.4% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 53.1M +12.1M +29.5% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 51.6M +16.6M +47.5% Dec 31, 2021 10-K 2023-03-01
Q3 2021 41.4M +6.42M +18.3% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 41.1M +6.12M +17.5% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 41M +6.01M +17.2% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 35M +6.87M +24.4% Dec 31, 2020 10-K 2022-03-01
Q3 2020 35M +9.13M +35.3% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 35M +9.22M +35.8% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 35M +9.18M +35.6% Mar 31, 2020 10-Q/A 2020-05-26
Q4 2019 28.1M +2.39M +9.28% Dec 31, 2019 10-K 2021-03-01
Q3 2019 25.9M +681K +2.7% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 25.8M +8.13M +46.1% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 25.8M +11.6M +81.9% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 25.8M +7.75M +43.1% Dec 31, 2018 10-K 2020-03-09
Q3 2018 25.2M +7.19M +39.9% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 17.6M -357K -1.99% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 14.2M -3.83M -21.3% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 18M +67.8K +0.38% Dec 31, 2017 10-K 2019-03-06
Q3 2017 18M +105K +0.59% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 18M +3.58M +24.9% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 18M +3.6M +25% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 17.9M +3.55M +24.6% Dec 31, 2016 10-K 2018-03-07
Q3 2016 17.9M +3.55M +24.7% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 14.4M +148K +1.04% Jun 30, 2016 10-Q 2016-08-03
Q1 2016 14.4M +179K +1.26% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 14.4M +204K +1.44% Dec 31, 2015 10-K 2017-03-08
Q3 2015 14.3M +13M +963% Sep 30, 2015 10-Q 2015-11-10
Q2 2015 14.3M Jun 30, 2015 10-Q 2015-08-13
Q1 2015 14.2M Mar 31, 2015 10-Q/A 2015-08-13
Q4 2014 14.2M +12.8M +955% Dec 31, 2014 10-K 2016-03-08
Q3 2014 1.35M Sep 30, 2014 10-Q 2014-12-15
Q4 2013 1.34M Dec 31, 2013 10-K 2015-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.